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The central memory T cell (TCM) model forms a unique HIV-1 latency model based on primary cells that closely
resemble in vivo TCM. The virus employed in this model is based on an engineered vector incapable of replication
after initial infection. We show that despite this strategy, replication competent viral particles are released into the
culture medium due to recombination between overlapping sequences of the env deleted HIV genome that is
co-transfected with intact env. This finding emphasizes the need for careful data analysis and interpretation if similar
constructs are employed and urges for additional caution during laboratory work.
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HIV latencyCommentary
The recent interest in HIV latency led to the develop-
ment of cell models recapitulating viral latency in vitro.
The TCM model published by Bosque and Planelles [1]
represents a widely used method. This model, based on
in vitro differentiated central memory cells combined
with a replication deficient virus, produces high numbers
of latently infected primary cells. Here, we show that the
viral construct used in this model can become replica-
tion competent due to recombination. We observed
spreading infection and high variability between repeated
experiments using this TCM model (Additional file 1:
Figure S2). This urges a re-analysis of the data and poses
important biosafety concerns on the use of similar viral
constructs.
The viral construct originally employed was produced
with an HIV-1NL4.3-derived viral vector-DHIV-containing
a 600 bp deletion in the env reading frame. This plasmid is
co-transfected with pLET-LAI-a plasmid containing the* Correspondence: linos.vandekerckhove@ugent.be
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article, unless otherwise stated.wild type env sequence from HIV-1LAI. Our data indi-
cate that the viral supernatant consists of a mix of single
round vectors and replication competent viruses, gener-
ated by recombination between the env sequences (Figure 1,
Additional file 1).
These results may not be surprising, considering the
stringent precautions taken in the field of lentiviral
transduction, requiring three or four (up to 7 a in super-
split system [2]) separate plasmids for co-transfection
[3,4]. However, two vector constructs are still often used
in basic HIV research. The current findings emphasize
the biosafety concern for laboratories working with vec-
tors that are assumed to be replication deficient, but can
become fully competent viruses. Moreover, these find-
ings urge a re-analysis of the published data derived
from the TCM model as well as from data using similar
constructs.
In the original paper describing the TCM model [1],
NFAT was characterized as the principal transcription
factor mediating reactivation of latent viruses after anti-
gen stimulation. Considering the current data, the role
of NFAT should be reassessed due to its potential in-
volvement in two different phenomena: reactivation
from latency and increasing viral replication kinetics asentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 (See legend on next page.)
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Figure 1 PCR and NGS-based confirmation of recombination between the DHIV and pLET-LAI constructs as a source of replication-competent
virus. To generate a vector capable of a single round of replication only, the vector employed in the original TCM model is produced with
the env-deficient DHIV construct co-transfected with intact env. Recombination between overlapping sequences of these plasmids restores
an intact env sequence in the viral genome and produces replication-competent virus. (cfr. Additional file 1). A-C. PCR based data A. Primer
pairs used in the study aligned to the envelope gene of DHIV construct. Primer pair ENV aligns to the common sequence of env of DHIV
and of the full length env, primer pair DEL aligns to the intact env sequence within the deleted part (dotted line) of DHIV. B-C. Electrophoretic
separation of PCR products performed on plasmid DNA-NL4.3-IRES-HSA-E* and DHIV (B) and on DNA from cells infected with the indicated viruses
(C). The positive signal in cells infected with DHIV + pLET-LAI indicates the presence of a full length env sequence in the viral DNA. D-F. Expression
of HIV RNA in the latent TCM model derived from RNA-Seq analysis of 4 donor cells infected with DHIV + pLET-LAI. D. The plot representing the number of
times individual nucleotides were mapped to the HIV genome. The delineated region indicates the env region deleted in the original DHIV. The high number
of mapped reads indicates that the complete env sequence is expressed. E-F. The plot representing reads spanning the deletion in DHIV env region at the
beginning (E) and end (F) of the deletion. Collectively, the electrophoretic analysis of integrated proviral DNA and the alignment of NGS reads in the region
originally containing a deletion in env indicate that an intact sequence of env was restored in the construct.
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required for reactivating latent viruses in TCM still needs
to be addressed. In accordance to this, the findings that
the JAK-STAT pathway [6] or PIM-1 [7] are required for
viral replication still hold, but the data cannot discern
whether the effect is due to inhibition of reactivation or
inhibition of virus replication kinetics.
In contrast to earlier interpretations [8], cellular p24
positive staining after antigen stimulation is not an un-
equivocal sign of reactivated virus, but rather a combin-
ation of that and spreading viral replication. Therefore,
the number of latently infected cells should be lower
than initially inferred. This is likely to impact deep se-
quencing and transcriptomic experiments.
A recent study compared integration sites between in-
duced and non-induced proviruses across five latency
models, including the TCM model [9]. An env(−) virus
was used in which nef was replaced with GFP. After in-
fection, GFP(−) cells (presumably, latently infected) were
sorted and cultured for 9 days prior to integration site
analysis [9]. Although the sorting strategy excluded HIV
producing cells, a minor fraction of early stage infected
cells which did not yet start producing GFP could be
present and introduce a bias to the data. The use of an
antiretroviral that blocks integration may have provided
a quantitative assessment of the extent of this bias.
Interestingly, in the TCM model there is a clear in-
crease in p24 positive cells between samples treated with
integrase inhibitors followed by antigen stimulation and
samples that are not stimulated. This indicates that a
fraction of the infected cells are latently infected despite
ongoing replication. Therefore, this model continues to
be valuable for HIV latency research. This is supported
by results that were corroborated in subsequent or par-
allel studies with alternative models.
In the study characterizing IL-7-mediated homeostatic
proliferation [10], cells were infected with a virus encod-
ing GFP and dividing and non-dividing GFP(−) cells
were sorted using a proliferation dye. Both subsetscarried integrated HIV DNA and were able to induce
viral production after antigen stimulation. The conclu-
sion that cells can undergo homeostatic proliferation in
the absence of viral production still holds, especially
considering the sorting strategy. This mechanism has
been supported by in vivo data [11]. Additionally, the
data showing that Pam3CSK4 [12] can reactivate HIV-1
was supported by two ex vivo experiments from HIV in-
fected aviremic patients. Similarly, the effect of romidep-
sin on HIV reactivation as found in a drug screen using
the TCM model was confirmed in an ex vivo model using
patient derived memory and resting CD4 + T-cells [13].
Increases in the p24 content due to reactivation from
post-integration latency occur rapidly. However, in-
creases in p24 due to viral replication are comparatively
slower, because each replication cycle requires entry, re-
verse transcription and integration. Consequently, biases
in experimental measurements will be smaller at shorter
readout times (e.g. 24 hours post reactivation), compared
to longer times (e.g. 72 hours post reactivation).
Conclusions
Replication competent viruses generated in simple co-
transfection systems may impact biosafety and bias re-
search results. Researchers should provide evidence
proving the replication incompetence of new constructs.
The findings impact earlier notions arising from the
TCM model and therefore the virus initially included as
part of this model cannot be used as originally described
[1]. However, the model may still be suitable to under-
stand HIV-1 latency provided that specific modifications
are introduced. There are two possible options here.
Efforts can be made to avoid recombination by imple-
mentation of envelope genes originating from non-HIV
species (e.g. VSV-G) [14], by utilizing split vector
systems such as these used in gene therapy or more
elaborate co-transfection systems with a proven lack of
recombination. Alternatively, the model can be used
with replication competent viruses in combination with
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tion. Finally, we would like to state for the record that we
are confident that cultured TCM generated as described by
Bosque and Planelles [1] continue to be a relevant and
suitable cell model for investigations of HIV infection and
latency/reactivation, and that the findings described herein
do not impact the methods for the generation of such cells
or their use in the laboratory.Additional file
Additional file 1: Experimental results supporting the recombination
and excluding laboratory contamination as a source of replication
competent virus in the Tcm model and materials and methods related
to the study.
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